Majority shareholder’s stake is reduced for surged pharmaceutical stocks in Q3
Percentage of ownership decreases for nine corporations Aprogen pharmaceuticalsㆍGreen Cross fell more than 0.5%p. CKD Bio +1.86%p… Samil Pharm +0.35%p
While pharmaceutical stocks fluctuated greatly after heating up in July and August and cooling down in September, the percentage of ownership decreased for a majority shareholder.
Based on Data Analysis, Retrieval and Transfer System, Newsmp found out that the percentage of ownership for the 9 majority shareholders dropped among 12 pharmaceutical corporations.
During this period, Aprogen Pharmaceuticals declined the most, which fell 0.97%p from 46.02% to 45.05%.
Green Cross decreased by 0.59%p from 52.82% to 52.23%, Korea United Pharm 0.25%p from 37.21% to 36.96%, and Wooridul Pharmaceutical 0.20%p from 6.83% to 6.63%.
In addition, Kwang Dong Pharmaceutical fell 0.08%p, Il-Yang Pharmaceutical 0.03%p, Ilsung Pharmaceutical 0.02%p, and DongKook Pharmaceutical and Dong What Pharm 0.01%p.
Meanwhile, CKD Bio’s percentage of ownership for majority shareholders jumped 1.86%9 from 37.30% to 39.16%. CKD Bio was the only pharmaceutical corporation whose ownership of the majority shareholder changed more than 1 percent in Q3.
Followed by CKD Bio, the percentage of Samil Pharmaceutical ownership rose 0.35%p from 38.50% to 38.85%, and Chong Kun Dang Pharmaceutical 0.01%p from 37.73% to 37.74%.
The stakes of Il Dong Pharmaceutical and Hana Pharm changed slightly, but there was no significant impact on their percentage of ownership.